241 results
Page 7 of 13
8-K
EX-99.1
emq ebohu34mf1n3nq
25 Nov 19
Alkermes Completes Acquisition of Rodin Therapeutics
5:26pm
8-K
EX-2.1
eh46r0
25 Nov 19
Alkermes Completes Acquisition of Rodin Therapeutics
5:26pm
8-K
EX-99.1
hhq0jmn8
18 Nov 19
Alkermes to Acquire Rodin Therapeutics
7:16am
8-K
EX-99.1
qtty40kqeq ojkkjmr
30 Oct 19
Biogen and Alkermes Announce FDA Approval of VUMERITY™ (diroximel fumarate) for Multiple Sclerosis
7:43am
8-K
EX-99.1
ji89gn918qk8s08 kx
23 Oct 19
Alkermes Plc Reports Third Quarter 2019 Financial Results and Implementation of Restructuring
7:05am
8-K
EX-99.2
c68zw
23 Oct 19
Alkermes Plc Reports Third Quarter 2019 Financial Results and Implementation of Restructuring
7:05am
8-K
EX-99.1
my0ma5 dpts8qori
13 Sep 19
Departure of Directors or Certain Officers
7:22am
8-K
EX-99.1
bbsijkkwa44bl2v9gw
30 Jul 19
Regulation FD Disclosure
7:46am
8-K
EX-99.1
1qjc9a92
25 Jul 19
Alkermes Plc Reports Second Quarter 2019 Financial Results
7:05am
8-K
EX-99.2
mvkrv0je0ndwv4zm
25 Jul 19
Alkermes Plc Reports Second Quarter 2019 Financial Results
7:05am
8-K
EX-99.1
5c4wr34
15 Jul 19
Regulation FD Disclosure
7:33am
8-K
EX-99.1
6cwxt
25 Apr 19
Alkermes Plc Reports First Quarter 2019 Financial Results
7:05am
8-K
EX-99.2
hudlz
25 Apr 19
Alkermes Plc Reports First Quarter 2019 Financial Results
7:05am
8-K
EX-99.2
vbn3 4edmm8v3p
14 Feb 19
Results of Operations and Financial Condition
7:05am
8-K
EX-99.1
etyafkcqcs
14 Feb 19
Results of Operations and Financial Condition
7:05am
8-K
EX-99.1
en2gmjt cx8uaxc1aw
1 Feb 19
Alkermes Receives Complete Response Letter From U.S. Food and Drug Administration for ALKS 5461 New Drug Application
4:33pm